In metastatic lymph nodes, CPS positivity was present in 27/38 (71.1%) oropharyngeal cancers and 19/28 (67.9%) oral cavity cancers, while TPS positivity was seen in 12/33 (36.4%) and 5/24 (20.8%), respectively. The gene discussed is CAD; the disease is oral cavity cancer.